BRIEF-Mylan CEO says it was never intended for patients to pay this price for Epipen-CNBC REUTERS 8:57 AM ET 8/25/2016 Aug 25 (Reuters) - Mylan CEO on CNBC-
* Mylan CEO on her salary increasing as Epipen prices rose: "I understand...that facts are inconvenient to headlines"
* It was never intended for patients to pay this price for Epipen
* We are letting patients take control of price by using savings card
* I am legislating access to Epipen ; says the system is broken
* If Epipen price reduced, we couldn't ensure everyone could have an epipen
* System incentivizes high price for drugs
* Says I have reached out to the senators
* On future price rises says we will continue to run a businees
* Says is ready to work with Congress
(c) Copyright Thomson Reuters 2016. Click For Restrictions - about.reuters.com/fulllegal.asp
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.